Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioblastoma × Radiotherapy, Intensity-Modulated × Clear all

Phase

Status

Completed 11 Terminated 4 Active not recruiting 2 Withdrawn 1 Unknown 1 Suspended 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 20 Squamous Cell Carcinoma of Head and Neck 8 Oropharyngeal Neoplasms 7 Prostatic Neoplasms 5 Carcinoma 4 Rectal Neoplasms 3 Nasopharyngeal Neoplasms 3 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Squamous Cell 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Stomatitis 2 Pancreatic Adenocarcinoma 2 Neoplasm Metastasis 2 Meningeal Carcinomatosis 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Tumor Virus Infections 1 Thyroid Carcinoma, Anaplastic 1 Stomatognathic Diseases 1 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1 Sarcoma 1 Recurrence 1

Interventions

Temozolomide 42 Radiotherapy 17 Magnetic Resonance Spectroscopy 14 pembrolizumab 12 Bevacizumab 12 Specimen Handling 11 Lomustine 11 Radiation 8 Cyclophosphamide 6 fludarabine 5 Nivolumab 4 Aminolevulinic Acid 4 olaparib 3 atezolizumab 3 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Ipilimumab 3 D2C7-(scdsFv)-PE38KDEL 3 regorafenib 2 fluciclovine F-18 2 contrast agent BR1 2 antisecretory factor 2 abemaciclib 2 Standard of Care 2 Restraint, Physical 2 Re-Irradiation 2 Radiation Dose Hypofractionation 2 Palliative Care 2 Oncolytic Virotherapy 2 ONC206 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05653635 2026-02-04

ReciDOPA

Centre Paul Strauss

Phase 2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡